Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-26-117604
Filing Date
2026-03-20
Accepted
2026-03-20 16:03:01
Documents
83
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-K/A d226768d10ka.htm   iXBRL 10-K/A 1817959
2 EX-23.1 d226768dex231.htm EX-23.1 3219
3 EX-31.1 d226768dex311.htm EX-31.1 10905
4 EX-31.2 d226768dex312.htm EX-31.2 10932
5 EX-32.1 d226768dex321.htm EX-32.1 4347
6 EX-32.2 d226768dex322.htm EX-32.2 4245
  Complete submission text file 0001193125-26-117604.txt   11449047

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA bntc-20250630.xsd EX-101.SCH 1484272
87 EXTRACTED XBRL INSTANCE DOCUMENT d226768d10ka_htm.xml XML 2722810
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-39267 | Film No.: 26778192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)